Elevated iNOS protein expression has been reported in approximately 30%–45% of human metastatic CRC cases and is significantly associated with poor patient survival (p < 0.01) (Ropponen et al., 2000; Zafirellis et al., 2010). Here, NOS2 is linked to colorectal carcinoma.